Spots Global Cancer Trial Database for hematologic, cytogenetic and molecular response rates and kinetics will be studied in addition to the safety of the combination
Every month we try and update this database with for hematologic, cytogenetic and molecular response rates and kinetics will be studied in addition to the safety of the combination cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Nilotinib + Pegylated Interferon Alpha 2a for Untreated Chronic Phase Chronic Myelogenous Leukemia | NCT01294618 | Chronic Myeloge... | Nilotinib,Novar... | 18 Years - | Hospices Civils de Lyon |